Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 330-337

  Boulay, Denis ^a   Duterte Boucher, Dominique ^a   Leroux Nicollet, Isabelle ^a   Naudon, Laurent ^a   Costentin, Jean ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; COCAINE; DESIPRAMINE; DIHYDROTETRABENAZINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; HALOPERIDOL; HOMOVANILLIC ACID; MAZINDOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; CARRIER PROTEINS; COCAINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; LOCOMOTION; MALE; MAZINDOL; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030425585     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ACKERMAN, J. M. AND WHITE, F. J.: AlO somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117: 181-187, 1990.
2. ACKERMAN, J. M. AND WHITE, F. J.: Decreased activity of rat AlO dopamine neurons following withdrawal from repeated cocaine. Eur. J. Pharmacol. 218: 171-173, 1992.
3. 3H GBR 12935 binding after chronic treatment with dopamine active drugs. Psychopharmacology 102: 2910-294, 1990.
4. BALDO, B. A. AND KELLEY, A. E.: Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor. Brain Res. Bull. 27: 105-108, 1991.
5. BAUMANN, M. H., CHAR, G. U., DE COSTA, B. R., RICE, K. C. AND ROTHMAN, R. B.: GBR 12909 attenuates cocaine-induced activation of meaolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271: 1216-1222, 1994.
6. BERGER, B. AND GLOWINSKI, J.: Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differenciation of catecholaminergic and serotoninergic terminals in rat cerebral structures. Brain Res. 147: 29-45, 1978.
7. BONNET, J.-J. AND COSTENTIN, J.: GBR12783 a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur. J. Pharmacol. 121: 199-209, 1986.
8. BOULAY, D., LEROUX-NICOLLET, I., DUTERTE-BOUCHER, D., NAUDON, L. AND COSTENTIN, J.: Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR12783. J. Neural Transm. (Gen. Sect.) 98: 209-215, 1994.
9. COYLE, J. J. AND SNYDER, S. H.: catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J. Pharmacol. Exp. Ther. 170: 221-231, 1969.
10. CUNNINGHAM, K. A. AND CALLAHAN, P. M.: Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104: 177-180, 1991.
11. CERRUTI, C., PILOTTE, N. S., UHL, G. AND KUHAR, M. J.: Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol. Brain Res. 22: 132-138, 1994.
12. DUTERTE-BOUCHER, D., KAMENKA, J. M. AND COSTENTIN, J.: Comparison of the effects of three indirect dopamine agonists, GK 13, GBR12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions. Psychopharmacology 101: 344-353, 1990.
13. GIFFORD, A. N. AND JOHNSON, K. M.: Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and the striatum. Pharmacol. Biochem. Behav. 41: 841-846, 1992.
14. GUDELSKY, G. A., NWAJEL, E. E., DEFIFE, C. AND NASH, J. F.: Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons. Synapse 12: 304-311, 1992.
15. HADFIELD, M. G. AND NUGENT, E. A.: Cocaine: Comparative effect on dopamine uptake in extrapyramidal and limbic systems. Biochem. Pharmacol. 32: 744-746, 1983.
16. HEIKKILA, R. E. AND MANZINO, L.: Behavioral properties of GBR12909, GBR13069 and GBR13098: specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103: 241-248, 1984.
17. HITRI, A. AND WYATT, R. J.: Regional differences in rat brain dopamine transporter binding: Function of time after chronic cocaine. Clin. Neuropharmacol. 16: 525-539, 1993.
18. HORN, A. S.: Characteristic of dopamine uptake. In The Neurobiology of Dopamine, ed. by A. S. Horn, J. Korf and B. H. C. Westerink, pp. 217-235, Academic Press, New York, 1979.
19. 3H]mazindol binding sites in rat striatum by dopaminergic agents. Eur. J. Pharmacol. 250: 261-266, 1993.
20. 3H dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res. 531: 338-341, 1990.
21. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244, 1991.
22. KALIVAS, P. W., SORG, B. A. AND HOOKS, M. S.: The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4: 315-334, 1993.
23. KELLEY, A. E. AND LANG, C. G.: Effect of GBR12909 a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. Eur. J. Pharmacol. 167: 385-395, 1989.
24. KIMELBERG, H. K.: Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes. Biochem. Pharmacol. 35: 2273-2281, 1986.
25. KING, E. H., ELLINWOOD, J. R., SILVA, C., JOYNER, C. M., XUR, Z., CARON, M. G. AND LEE, T. H.: Withdrawal from continuous or intermittent cocaine administration: change in D2 receptor function. J. Pharmacol. Exp. Ther. 269: 743-749, 1994.
26. KULA, N. S. AND BALDESSARINI, R. J.: Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 30: 89-92, 1991.
27. MCMILLEN, B. A.: Comparative effects of classical and atypical antipsychotic drugs in combination with a non-amphetamine stimulant on rat brain dopamine metabolism. J. Pharm. Pharmacol. 33: 544-546, 1981.
28. NG, J. P., HUBERT, G. W. AND JUSTICE, J. B. JR.: Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry. J. Neurochem. 56: 1485-1492, 1991.
29. PARSONS, L. H., SMITH, A. D. AND JUSTICE, J. B. JR.: Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9: 60-65, 1991.
30. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
31. PELTON, E. W., KIMELBERG, H. K., SHEPHERD, S. W. AND BOURKE, R. S.: Dopamine and noradrenaline uptake and metabolism by astroglial cells in culture. Life Sci. 28: 1655-1663, 1981.
32. PENNARTZ, C. M. A., GROEKEWEGEN, H. J. AND LOPES DA SILVA, F. H.: The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioral, electrophysiological and anatomical data. Prog. Neurobiol. 42: 719-761, 1994.
33. PERIS, J., BOVSON, S. J., CASS, W. A., CURELLA, P., DWOSKIN, L. P., LARSON, G., YASUDA, R. P. AND ZAHNISER, N. R.: Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253: 38-44, 1990.
34. PILOTTE, N. S., SHARPE G. L. AND KUHAR, M. J.: Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens. J. Pharmacol. Exp. Ther. 269: 963-969, 1994.
35. PONTIERI, F. E., COLANGELO, V., LA RICCIA, M., POZZILLI, C., PASSARELLI, F. AND ORZI, F.: Psychostimulant drugs increase glucose utilization in the shell of the rat nucleus accumbens. Neuroreport 5: 2561-2564, 1994.
36. POST, R. M., LOCKFELD, A., SQUILLACE, K. M. AND CONTEL, N. R.: Drug environment interaction: Context dependency of cocaine induced behavioral sensitization. Life Sci. 28: 755-760, 1981.
37. REITH, M. E. A., MEISLER, B. E., SERSHEN, H. AND LAJTHA, A.: Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35: 1123-1129, 1986.
38. ROBINSON T. E. AND BERRIDGE K. C.: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
39. ROBLEDO, P. AND KOOB, G. F.: Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav. Brain Res. 55: 159-166, 1993.
40. ROTHMAN, R. B.: High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci. 46: PL 17-21, 1990.
41. SEGAL, D. S. AND KUCZENSKI, R.: Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577: 351-355, 1992.
42. 3H] Mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203: 141-144, 1991.
43. SHORE, P. A.: Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J. Pharm. Pharmacol. 28: 855-857, 1976.
44. SOARES-DA-SILVA, P. AND GARBETT, M. C.: Overflow of endogenous dopamine and 3,4-dihydroxyphenylacetic acid from tissues of the rat brain, elicited by electrical stimulation, depolarization by potassium and activation of carriermediated release. Neuropharmacology 29:1151-1159, 1990.
45. STEWART, J., DE Wrr H. AND EIKELBOOM, R.: Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91: 251-268, 1984.
46. VAN DER ZEE, P., KOGER, H. S., GOOTJES, J. AND HESPE, W.: Aryll,4 Dialkenylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15: 363-370, 1980.
47. 3H] GBR12783. Eur. J. Pharmacol. 210: 77-84, 1992.
48. WESTERINK, B. H. C., DAMSMA, G., DE VRIES, J. B. AND KONING, H.: Dopamine reuptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur. J. Pharmacol. 135: 123-128, 1987.
49. 3H]-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14: 2966-2979, 1994.
50. WOOLVERTON, W. L. AND JOHNSON, K. M.: Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13: 193-200, 1992.
51. 3H]dopamine. Neuropharmacology 29: 475-483, 1990.
52. ZETTERSTRÖM, T., SHARP, T., COLLIN, A. K. AND UNGERSTEDT, U.: In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148: 327-334, 1988.